InsidersTradesSigma
Follow the Spectrum Pharmaceuticals INC stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Spectrum Pharmaceuticals INC has published 55 public disclosures. The latest transaction was disclosed on 1 August 2023 (Disposition). Among the most active insiders: McGahan Keith M. The full history is accessible without an account.
55
Insider Decl.
n/a
Thresholds
€21,793
1 ops.
Buy Volume
€297,303
34 ops.
Sell Volume
37Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 August 2023
Declarations55 total
27,380 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017680:0
54,066 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017672:0
295,244 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017668:0
317,474 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017669:0
29,759 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017677:0
104,823 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017673:0
67,660 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017675:0
195,485 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017679:0
463,005 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017673:1
32,387 shares@ US$1.096100.0% of flowCommon Stock, $0.001 par valueSEC:0000950170-23-025014:0
15,733 shares@ US$0.81917.9% of flowCommon Stock, $0.001 par valueSEC:0000950170-23-008619:0
18,153 shares@ US$0.81912.5% of flowCommon Stock, $0.001 par valueSEC:0000950170-23-008618:0
11,990 shares@ US$0.76112.8% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-006112:0
14,607 shares@ US$0.7619.4% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-006110:0
69,389 shares@ US$0.54431.4% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-003144:0
26,138 shares@ US$0.54419.5% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-003145:0
23,929 shares@ US$0.3827.7% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-001066:0
222,000 shares0Common Stock, $0.001 par valueSEC:0000899243-23-001065:0
240,000 shares0Common Stock, $0.001 par valueSEC:0000899243-23-001064:0
50,000 shares@ US$0.4544.1% of flowCommon Stock, $0.001 par valueSEC:0000899243-22-037526:0
Canonical exit: 28 Feb 2023 (T+90)
50,000 shares@ US$0.4343.7% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-054744:0
25,000 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048515:0
25,000 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048520:0
27,380 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048497:0
25,000 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048461:0
25 of 55 declarations
Acerca de Spectrum Pharmaceuticals INC
Geográficamente, Spectrum ha operado principalmente desde los Estados Unidos y atiende al mercado estadounidense, con exposición al sistema de atención médica, los pagadores y los canales de distribución hospitalaria del país. Los archivos de la SEC también muestran la dependencia de fabricantes externos para ciertos insumos, ingredientes farmacéuticos activos y servicios de logística, lo cual es importante al evaluar la resiliencia operativa. En resumen, Spectrum Pharmaceuticals Inc. sigue siendo una acción biofarmacéutica estadounidense que cotiza en el NASDAQ, con un perfil especializado y de mayor riesgo, cuya historia reciente se ha definido por la contracción de la cartera, el reenfoque estratégico y una mayor dependencia de un conjunto limitado de catalizadores clínicos y comerciales.
